Michael Storek

Michael Storek

Company: Sanofi

Job title: Head of Complement Cluster

Seminars:

Panel Discussion: Defining the Therapeutic Windows of Drugs to Ensure Patient Safety Whilst Maintaining Drug Efficacy 9:50 am

Balancing the therapeutic index versus safety in targeting complement Discussing this in the context of disease versus healthy complement inhibition Reviewing the therapeutic window when you target classical, lectin or alternative pathways Discussing pharmacokinetics of targeting complement Specifying inclusion/exclusion criteria put in place specifically due to safety considerations e.g. avoiding comorbidities or infectionsRead more

day: Day One

Complement Industry Leaders’ Chat – 2021/22 in Review & Looking Ahead 8:40 am

This panel will discuss the key breakthroughs that have happened this year, the key challenges that have been overcome and where the biggest excitement remains: How do you perceive the complement drug development space? How has this changed in the past 12 months? What is missing from complement drug discovery and translation into the clinic?…Read more

day: Day One

Chair’s Opening Remarks 8:30 am

Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.